Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 27, 2026Current HIV/AIDS ReportsOpen Access

HSV, HIV, and Pregnancy: Epidemiology, Viral Interactions, Management, and Prevention

View Full Paper
Ask AI
Bookmark
Share

Authors

SHSheliza HalaniMYMark H. YudinDTDarrell H. S. Tan

Discussion

Loading...

Member takes

Overview

Randomized trial explores HSV-2 and HIV management in pregnancy, suggesting effective interventions exist.

Key Points

  • This research addresses the epidemiology and interactions between HSV-2 and HIV during pregnancy and their management.
  • Summarized epidemiological data on HSV-2 and HIV seroprevalence in pregnancy.
  • Reviewed management strategies for reducing vertical transmission of HIV and HSV-2.
  • Assessed the effectiveness of acyclovir and valacyclovir in recurrent genital herpes cases during pregnancy.
  • HSV-2 seroprevalence is higher among women living with HIV, impacting vertical transmission risk.
  • Maternal ART significantly reduces vertical HIV transmission and potentially impacts HSV-2 shedding.
  • Acyclovir and valacyclovir are recommended to reduce herpes recurrence risks during pregnancy.

Cite This Study

Halani et al. (2026) studied this question.

synapsesocial.com/papers/6a67008840bca442e0d4a496https://doi.org/10.1007/s11904-026-00793-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Maternal–Fetal Implications of Herpes Virus Infection: An Updated Review2026
  2. 2Management of Genital Herpes Simplex Virus Infection for the Pregnant Woman2024
  3. 3High prevalence of herpes simplex virus (HSV)- type 2 co-infection among HIV-positive women in Ukraine, but no increased HIV mother-to-child transmission risk2016 · 15 citations
  4. 4Global prevalence of herpes simplex virus among pregnant women: a systematic review and meta-analysis2026
  5. 5P-513. Outcomes of antenatal antiviral suppressive therapy at 36 weeks gestation in a large cohort of pregnant persons with genital herpes simplex virus2026